Out of 18 legally blind patients with progressive eye diseases, more than half reported greatly improved vision after having human embryonic stem cells infused into their retinas.
"I'm astonished that this is working in the way that it is — or seems to be working," Steven Schwartz, a UCLA eye specialist who led the study, told NPR. "I'm very excited about it."
The study participants had age-related macular degeneration and Stargardt's macular dystrophy, the leading causes of blindness in the developed world. Researchers did not expect the patients to regain any sight, and were just trying to determine if it was a safe procedure.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Human embryonic stem cells can become any type of cell in the body, and researchers turned them into retinal pigment epithelial cells. Between 50,000 and 150,000 cells were infused into the retinas of patients, replacing dying tissue with new tissue. Soon, 10 patients could see significantly better, seven saw better or didn't lose any additional vision, and one was worse. "These are patients that didn't see better for 30 years and all of a sudden they're seeing better," Schwartz said. "It's amazing."
The results were the first for any human embryonic stem cell trial approved by the FDA, but they're considered preliminary because the number of patients treated was very small, and they were only followed for an average of less than two years. Many said their lives have changed for the better — one elderly rancher can ride his horse again, and a consultant who travels internationally is able to walk unassisted through airports — but Schwartz notes that the procedure is "not ready," and won't be for at least a few years: "We have to wait and see. The jury is way out still."
The findings were published Tuesday in The Lancet.
-
Fannie Flagg’s 6 favorite books that sparked her imaginationFeature The author recommends works by Johanna Spyri, John Steinbeck, and more
-
Google: A monopoly past its prime?Feature Google’s antitrust case ends with a slap on the wrist as courts struggle to keep up with the tech industry’s rapid changes
-
Patrick Hemingway: The Hemingway son who tended to his father’s legacyFeature He was comfortable in the shadow of his famous father, Ernest Hemingway
-
SpaceX breaks Starship losing streak in 10th testspeed read The Starship rocket's test flight was largely successful, deploying eight dummy satellites during its hour in space
-
Rabbits with 'horns' sighted across Coloradospeed read These creatures are infected with the 'mostly harmless' Shope papilloma virus
-
Lithium shows promise in Alzheimer's studySpeed Read Potential new treatments could use small amounts of the common metal
-
Scientists discover cause of massive sea star die-offSpeed Read A bacteria related to cholera has been found responsible for the deaths of more than 5 billion sea stars
-
'Thriving' ecosystem found 30,000 feet underseaSpeed Read Researchers discovered communities of creatures living in frigid, pitch-black waters under high pressure
-
New York plans first nuclear plant in 36 yearsSpeed Read The plant, to be constructed somewhere in upstate New York, will produce enough energy to power a million homes
-
Dehorning rhinos sharply cuts poaching, study findsSpeed Read The painless procedure may be an effective way to reduce the widespread poaching of rhinoceroses
-
Breakthrough gene-editing treatment saves babyspeed read KJ Muldoon was healed from a rare genetic condition
